Arcellx (ACLX) Total Non-Current Liabilities (2021 - 2025)

Arcellx's (ACLX) quarterly Total Non-Current Liabilities came in at $201.6 million in Q4 2025, down 18.67% year-on-year from $247.9 million in Q4 2024, and down 6.28% quarter-over-quarter from $215.1 million in Q3 2025.

Arcellx (ACLX) Total Non-Current Liabilities (2021 - 2025) Analysis & Trends

Arcellx's Total Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $201.6 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 18.67% year-over-year to $201.6 million in Q4 2025; TTM through Dec 2025 was $201.6 million, a 18.67% decrease from a year earlier, with the FY2025 full-year figure at $201.6 million, down 18.67% from the prior year.
  • Total Non-Current Liabilities declined to $201.6 million in Q4 2025 per ACLX's latest filing, from $215.1 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $267.7 million in Q1 2024 and bottomed at $16.7 million in Q4 2021.
  • The 4-year median for Total Non-Current Liabilities is $226.9 million (2025), against an average of $179.3 million.
  • Biggest YoY gain for Total Non-Current Liabilities was 2.32% in 2025; the steepest drop was 19.38% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $16.7 million in 2021, then surged by 204.22% to $50.9 million in 2022, then soared by 386.86% to $247.9 million in 2024, then declined by 18.67% to $201.6 million in 2025.
  • Per Business Quant, the three latest ACLX Total Non-Current Liabilities figures stand at $201.6 million (Q4 2025), $215.1 million (Q3 2025), and $226.9 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 201.64 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 201.64 Mn
Sep 30, 2025 215.14 Mn
Jun 30, 2025 226.86 Mn
Mar 31, 2025 227.74 Mn
Dec 31, 2024 247.94 Mn
Sep 30, 2024 266.84 Mn
Jun 30, 2024 232.24 Mn
Mar 31, 2024 267.65 Mn
Jun 30, 2022 50.93 Mn
Mar 31, 2022 18.90 Mn
Dec 31, 2021 16.74 Mn